Pharmablock Sciences announces early redemption of "Yaoshi" convertible bonds

Pharmablock Sciences (Nanjing) will compulsorily redeem its "Yaoshi convertible bonds" (stock code: 123145) at 100.62 yuan per bond, including accrued interest, by September 17, 2025, after market close. This follows the company's stock price meeting the redemption condition of 130% of the current conversion price (43.69 yuan per share) for at least 15 trading days within a 30-day period, from July 25, 2025, to August 14, 2025.

Trading of the bonds will cease on September 15, 2025, and conversion to shares will stop on September 18, 2025. Bondholders are advised to unpledge or unfreeze their bonds before the conversion deadline to avoid redemption without conversion. Failure to convert by the deadline may result in losses due to the significant difference between the secondary market price and the redemption price.

The company also adjusted its estimated daily related-party transactions for 2025, increasing projected sales of goods and provision of services to Jiangsu Nanchuang Chemical and Life Health Research Institute Co., Ltd. from 1m yuan to 2.5m yuan. This adjustment was approved by the board of directors and independent directors, reflecting the company’s operational needs.